Tumor Budding Significance as a Biomarker for Clinicopathology and Prognostic Evaluation in Gynecological Malignancy: A Bayesian Meta-Analysis
Key Points
The aim is to assess the significance of tumor budding as a prognostic biomarker in gynecological malignancies.
Conducted a Bayesian meta-analysis of existing literature
Evaluated the association between tumor budding and clinicopathological features
Assessed the prognostic implications of tumor budding in patients with gynecological malignancy
Tumor budding shows a significant association with clinicopathological features
Strong correlation with worse prognosis in gynecological malignancies
Findings suggest that tumor budding could inform clinical assessments
Abstract
Tumor budding is significantly associated with clinicopathological features and prognosis in patients with gynecological malignancies.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Tumor Budding Significance as a Biomarker for Clinicopathology and Prognostic Evaluation in Gynecological Malignancy: A Bayesian Meta-Analysis | Synapse